<DOC>
	<DOCNO>NCT01196377</DOCNO>
	<brief_summary>Our overall objective model pediatric Acute Asthma Clinical Decision Rule ( ADR ) personalize medicine identification treatment-response phenotype important determinant outcome . The Specific Aim study determine feasibility approach enrol pilot cohort 16 participant DBRCT 4 different albuterol treatment regimen , 2 use 10mg/hr 2 use 25mg/hr . Within dosage pulsed-treatment regimen continuous regimen .</brief_summary>
	<brief_title>Optimal Albuterol Regimens Acute Asthma Exacerbations : DBRCT Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Status Asthmaticus</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Doctor diagnose asthma Acute asthma exacerbation Treatment systemic corticosteroid nebulized albuterol Ages 5 17 year Other acute chronic lung disease</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Acute asthma</keyword>
	<keyword>Pediatrics</keyword>
</DOC>